✦ LIBER ✦

The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug

✍ Scribed by Paul A.J. Janssen; Carlos J.E. Niemegeers; Karel H.L. Schellekens; Fred M. Lenaerts; Frans J. Verbruggen; Jan M. Van Nueten; Wolfgang K.A. Schaper

Book ID: 118320406
Publisher: Elsevier Science
Year: 1970
Tongue: English
Weight: 912 KB
Volume: 11
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(70)90043-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Pharmacology of a New Potent, Long A

The Pharmacology of a New Potent, Long Acting Neuroleptic, Piflutixol

✍ Nielsen, I. Møller ;Boeck, V. ;Christensen, A. V. ;Danncskiold-Samsøe, P. ;Hytte 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 693 KB

Discovery and Preclinical Profile of Sax

Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khan 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 214 KB

Carboxylic ionophores: A new class of dr

Carboxylic ionophores: A new class of drugs acting on the coronary circulation: P. Somani, G.G. Kabell, R.K. Saini, and R. Kelley Hester Department of Pharmacology, Univ. of Miami School of Medicine, Miami Florida, U.S.A.

📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 79 KB

8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-yn

8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes†

✍ Eckhardt, Matthias; Langkopf, Elke; Mark, Michael; Tadayyon, Moh; Thomas, Leo; N 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 235 KB